Abstract

Interactions Between Treatment and Continuous Covariates: A Step Toward Individualizing Therapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
P5-13-19: Borderline Estrogen and Progesterone Receptor Expression and Efficacy of Anti-Estrogen Therapy Analyzed by Subpopulation Treatment Effect Pattern Plot Analysis.
S-W Luoh ... E Keenan
Cancer Research | VOL. 71
S-W Luoh, et. al.S-W Luoh ... E Keenan
15 Dec 2011
Quantitative Progesterone Receptor Expression and Efficacy of Anti-estrogen Therapy in Breast Cancer
Shiuh-Wen Luoh ... Betsy Ramsey
The Breast Journal | VOL. 20
Shiuh-Wen Luoh, et. al.Shiuh-Wen Luoh ... Betsy Ramsey
22 Nov 2013
Hormone-Related Factors Associated with Hormone Receptor Levels in Breast Cancer
Leobardo Calzada ... Teresita Sandoval
Gynecologic and Obstetric Investigation | VOL. 52
Leobardo Calzada, et. al.Leobardo Calzada ... Teresita Sandoval
01 Nov 2001
Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors—International Breast Cancer Study Group
Monica Castiglione-Gertsch ... Anikó Kovács
Journal of Clinical Oncology | VOL. 26
Monica Castiglione-Gertsch, et. al.Monica Castiglione-Gertsch ... Anikó Kovács
20 Mar 2008
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers